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We examined the prevalence of Chlamydia trachoma-
tis infection in Israeli female soldiers. The prevalence was
3.2% among soldiers seeking medical care; rural residence
was identified as a significant risk factor. Nevertheless,
given the study design, recommending broad-scale screen-
ing of Israeli female soldiers may be premature. 
R
ecent studies from the United States and Europe report
that the prevalence of Chlamydia trachomatis ranges
from 5% to 20% in sexually active persons (1,2). Among
women, the consequences of the disease include pelvic
inflammatory disease, ectopic pregnancy, and infertility,
sequelae often accompanied by a substantial economic
impact (3). Most importantly, for up to 80% of infected
women, infection is asymptomatic, resulting in failure to
seek timely medical care and the exacerbation of such
sequelae (4). Consequently, screening programs have been
recommended to reduce infection, transmission, and dis-
ease consequences (4,5). However, before such programs
are universally advocated, since the cost-effectiveness of
such control programs is at least partially contingent upon
disease prevalence (5), more data are required to assess the
extent to which such prevalence rates may indeed be gen-
eralizable to other countries and populations.
Epidemiologic research indicates that prevalence rates
of  C. trachomatis vary, with a number of risk factors
accounting for a substantial portion of this variance (4).
For example, in the landmark study by Gaydos et al., sig-
nificant risk factors for the prevalence of this infection
among American female military recruits included age
(women <25 years of age were at higher risk), vaginal
intercourse, lack of condom use, and multiple sexual part-
ners (4). Given that sexual practices such as condom use
and multiple sex partners are likely to vary from country to
country, we designed a study to assess the prevalence of C.
trachomatis in a population of Israeli women, namely
female soldiers, who, according to previous research, had
a heightened risk of having the disease because of their age
and sexual activity (4–6). 
The Study
Whereas Gaydos et al. invited all female army recruits
undergoing a physical examination at a reception base over
the course of 2-year period to participate in their study, our
sample consisted of Israeli women actively seeking med-
ical care. Specifically, participants in the current study
were women serving in the Israel Defense Forces, who,
over a 12-month period attended a women’s health clinic
for a routine gynecologic examination, treatment of geni-
tourinary symptoms, or contraceptive counseling. The
clinic was associated with a major tertiary hospital in
northern Israel. Of the 800 women we asked, 708 volun-
teered to participate, for a response rate of 88.5%.
Participants were between the ages of 18 and 45 (median
age 19, mean age 20). Most participants (77%) were born
in Israel. 
After signing an informed consent form, participants
were asked to complete a short questionnaire (including
demographic and sexual history items) and provide a urine
specimen. We performed the polymerase chain reaction
(PCR) of urine specimens to test for C. trachomatis and
Neisseria gonorrhoeae (Roche Amplicor, Branchburg,
NJ). The PCR results and questionnaire data were coded as
dichotomous variables and examined on the basis of both
univariate (chi-square and Fisher exact test) and multivari-
ate (logistic regression) analysis. 
Of the 708 participants, 23 (3.25%) tested positive for
C. trachomatis, and 8 (1%) tested positive for N. gonor-
rhoeae. These rates are substantially lower than the 9.2%
prevalence rate for C. trachomatis reported by Gaydos in
the U. S. military study (4). The median and average age
of those affected was 20. Most of those testing positive
reported 1) having had sex in the past 3 months (86%), 2)
having had more than one partner (45%) or having had a
partner who had had more than one partner (57%), or 3)
never having used a condom (70%) (Table). Nevertheless,
none of these factors, identified by Gaydos as significant
risk factors in the American sample, was found to be a sig-
nificant predictor of C. trachomatis infection in the Israeli
soldiers. Similarly, while most of those testing positive
were born in Israel (81%), country of origin was not a sig-
nificant predictor of infection. Neither were gynecologic
symptoms found to significantly distinguish between C.
trachomatis–positive and –negative soldiers. Indeed, the
only factor that we found to significantly distinguish
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urban versus rural residence. Specifically, rural residents
were significantly more likely to be positive for C. tra-
chomatis than urban residents (chi square=3.86, p<0.05).
Similarly, in a logistic regression analysis, only rural resi-
dence was significantly associated with Chlamydia infec-
tion (p=0.043) (Table).
Conclusions
The relatively low rate of C. trachomatis prevalence
was somewhat surprising for several reasons. First, since
1994, when Chlamydia infection became a nationally noti-
fiable infectious disease in Israel, the number of cases
reported annually has risen 10-fold. Secondly, since 2000,
14% of symptomatic soldiers attending the sexually trans-
mitted disease clinic of another major medical center in
northern Israel were diagnosed with Chlamydia infection.
Finally, while Gaydos et al. found a 9.2% prevalence rate
in a sample of soldiers reporting for a general physical
examination, our sampling strategy focused on women
who had a high probability of being sexually active (i.e.,
seeking contraceptives) and consequently, according to the
previous literature, were at higher risk of contracting
asymptomatic C. trachomatis infection (5). 
However, oversampling those most concerned with
their health (i.e., “the worried well”) may partially explain
the lower than expected prevalence rate. Indeed, given the
risk for a self-selection bias inherent in such a sampling
strategy, one important limitation of the current study is
that the sample population may not be entirely representa-
tive of the entire population of female soldiers in the Israeli
Defense Forces. Asecond limitation is that the Roche PCR
kit used in this study was not cleared by the Food and Drug
Administration for testing female urine samples for N.
gonorrhoeae because of its low sensitivity. Consequently,
the actual prevalence of gonorrhea may in fact be higher
than reported above.
Given the nearly universal draft of young Jewish
females in Israel, however, our results may provide a
strong indication of the prevalence of C. trachomatis in
young, sexually active Jewish women in that country.
Despite the relatively low rate of prevalence, based on a
number of cost-efficacy studies (6,7) and consistent with
the recommendations of the Centers for Disease Control
and Prevention (5), focused screening of asymptomatic,
sexually active female soldiers, by virtue of their age, may
be a cost-effective mode for identifying those with C. tra-
chomatis infection in Israel. Identifying gonorrhea in 1%
of the women tested shows an important secondary benefit
to such screening. Nevertheless, before recommending the
adoption of a broader, more focused screening program of
female soldiers, whether symptomatic or not, we recom-
mend collecting additional data with a more randomized
sampling strategy similar to that adopted by Gaydos et al.
(4). Were an equivalent or higher prevalence rate to be
found in a random sample of female soldiers during their
service, then, according to recent estimates of cost-effec-
tiveness (7,8), such a screening program would be worthy
of consideration. 
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